These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26316243)

  • 1. Menopause and the Heart.
    Nkonde-Price C; Bender JR
    Endocrinol Metab Clin North Am; 2015 Sep; 44(3):559-64. PubMed ID: 26316243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does hormone replacement therapy in menopause have a cardiovascular benefit?].
    Scarabin PY
    Rev Med Interne; 2003 Apr; 24(4):216-7. PubMed ID: 12706776
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular aspects of menopausal hormone replacement therapy.
    Rosano GM; Vitale C; Fini M
    Climacteric; 2009; 12 Suppl 1():41-6. PubMed ID: 19811240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of hormone replacement therapy in postmenopausal women with type 2 diabetes.
    Cefalu WT
    J Womens Health Gend Based Med; 2001 Apr; 10(3):241-55. PubMed ID: 11389784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of diseases after menopause.
    Lobo RA; Davis SR; De Villiers TJ; Gompel A; Henderson VW; Hodis HN; Lumsden MA; Mack WJ; Shapiro S; Baber RJ
    Climacteric; 2014 Oct; 17(5):540-56. PubMed ID: 24969415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
    Sturdee DW; Pines A; ; Archer DF; Baber RJ; Barlow D; Birkhäuser MH; Brincat M; Cardozo L; de Villiers TJ; Gambacciani M; Gompel AA; Henderson VW; Kluft C; Lobo RA; MacLennan AH; Marsden J; Nappi RE; Panay N; Pickar JH; Robinson D; Simon J; Sitruk-Ware RL; Stevenson JC
    Climacteric; 2011 Jun; 14(3):302-20. PubMed ID: 21563996
    [No Abstract]   [Full Text] [Related]  

  • 15. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 16. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
    Harman SM
    Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopause and hormone replacement therapy.
    Johnson SR
    Med Clin North Am; 1998 Mar; 82(2):297-320. PubMed ID: 9531927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
    Shapiro S
    Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.